Role of protein kinase C in glucose- and angiotensin II-induced plasminogen activator inhibitor expression

Contributions to Nephrology

Volumn 118, Issue , 1996, Pages 180-187

  Feener, Edward P ^a   Xia, Pu ^a   Inoguchi, Toyoshi ^a   Shiba, Teruo ^a   Kunisaki, Makoto ^a   King, George L ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DIACYLGLYCEROL; GLUCOSE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; GENETICS; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; DIGLYCERIDES; GLUCOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0029692743     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (31)

1. Osterby R: Early phases in the development of diabetic glomerulosclerosis. Acta Med Scand 1975;574:1-80.
2. Steffes MW, Mauer SM: Diabetic glomerulopathy: A morphological approach to monitoring development, progression and reversibility. Diabet Nephrop 1985;4:114-117.
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
4. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warrant JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251-1255.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
6. Nishio Y, Aiello LP, King GL: Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display, FASEB J 1994;8:103-106.
7. Aiello LP, Robinson GS, Lin YW, Nishio Y, King GL: Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose using mRNA differential display. Proc Natl Acad Sci USA 1994;91:6231-6235.
8. Feener EP, Northrup JM, Aiello LP, King GL: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995;95:1353-1362.
9. King GL, Goodman AD, Buzney S, Moses A, Kahn CR: Receptors and growth promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985;75:1028-1036.
10. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhame L, Chardon D, Kirilovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-15781.
11. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89:11059-11063.
12. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 1994;267:369-379.
13. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994;43:1122-1129.
14. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell SE, King GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 1993;265: E783-E793.
15. Craven PA, Davidson CM, DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 1990;39:667-674.
16. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 1989;83:1667-1675.
17. Studer RK, Craven PA, DeRubertis FR: Role of protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 1993;42:118-126.
18. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, Luft FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 1995;47:1057-1067.
19. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J: Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 1991;87:31-38.
20. Schved JF, Gris JC, Martinex P, Sarlat C, Sanchez N, Arnaud A: Familial thrombophilia associated with familial elevation of plasma histidine rich glycoprotein and type 1 PAI. Thromb Haemost 1991;65:1044.
21. Vaughan DE, Lazos SA, Tong K: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 1995;95:995-1001.
22. van Leeuwen RTJ, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G: Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 1994;90:362-368.
23. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE: Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994;43:104-109.
24. Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA: Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care 1994;17:818-823.
25. Auwerx J, Bouillon R, Collen D, Geboers J: Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988;8:68-72.
26. Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P: Increased plasminogen activator inhibitor activity in non-insulin-dependent diabetic patients: Relationship with plasma insulin. Thromb Haemost 1989;61:370-373.
27. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Fuolo A, Pagano G: PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994;43:426-429.
28. Vassalli J, Sappino A, Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
29. Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T: Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 1992;202:471-476.
30. Baricos WH, Cortez SL, El-Dahr SS, Schnaper HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 1995;47:1039-1047.
31. Nordt TK, Klassen KJ, Schneider DJ, Sobel BE: Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb 1993;13:1822-1828.